News for December 8th, 2008

Risk factors may indicate serious skin reaction to lamotrigine

Children treated with lamotrigine for epilepsy who have a medical history of skin reactions to medication, use multiple drug therapies including the drug valproate, and cannot be adequately control their seizures with medication may be at greater risk for adverse skin reactions, according to Peer View Media Bar.

Lamotrigine is an anticonvulsant drug to treat partial seizures, primary and secondary tonic-clonic seizures in epilepsy and seizures associated with Lennox-Gastaut syndrome. It also is FDA-approved to treat bipolar disorder.

Read the rest of this entry »